Cargando…

Efficacy and safety of intense pulsed light direct eyelid application

To describe the efficacy and safety of intense pulsed light (IPL) applied directly on the eyelids of patients with Meibomian gland dysfunction (MGD) without corneal shield protector. Observational retrospective single centre study where patients underwent 3 treatment sessions of IPL with 2 weeks of...

Descripción completa

Detalles Bibliográficos
Autores principales: Martínez-Hergueta, María C., Alió del Barrio, Jorge L., Canto-Cerdan, Mario, Amesty, María A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9481572/
https://www.ncbi.nlm.nih.gov/pubmed/36114213
http://dx.doi.org/10.1038/s41598-022-17986-3
_version_ 1784791299112566784
author Martínez-Hergueta, María C.
Alió del Barrio, Jorge L.
Canto-Cerdan, Mario
Amesty, María A.
author_facet Martínez-Hergueta, María C.
Alió del Barrio, Jorge L.
Canto-Cerdan, Mario
Amesty, María A.
author_sort Martínez-Hergueta, María C.
collection PubMed
description To describe the efficacy and safety of intense pulsed light (IPL) applied directly on the eyelids of patients with Meibomian gland dysfunction (MGD) without corneal shield protector. Observational retrospective single centre study where patients underwent 3 treatment sessions of IPL with 2 weeks of interval. The IPL was carried out with Lumenis OPT M22 with a double pass technique of 12 impacts on the infraorbital/lower eyelid region with the 15 × 35 mm guide light (step 1) and a double pass technique of 3 impacts over the upper eyelids with the 8 × 15 mm guide light (step 2). The follow up was conducted through Oculus Keratograph 5 M. 30 patients were enrolled in the study. Although there were no significant differences (p > 0.05), non-invasive tear break-up time, ocular redness, and OSDI questionnaire improved during the 3 IPL sessions. A significant improvement (p = 0.024) in the percentage of meibomian gland loss was also observed. Regarding tear meniscus, it was found similar measurements before and after treatment. No serious adverse effects were reported during the procedure or in subsequent follow-up. Preliminary results suggest that IPL therapy applied directly on the eyelids without corneal shield could be safe and effective in the treatment of MGD.
format Online
Article
Text
id pubmed-9481572
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-94815722022-09-18 Efficacy and safety of intense pulsed light direct eyelid application Martínez-Hergueta, María C. Alió del Barrio, Jorge L. Canto-Cerdan, Mario Amesty, María A. Sci Rep Article To describe the efficacy and safety of intense pulsed light (IPL) applied directly on the eyelids of patients with Meibomian gland dysfunction (MGD) without corneal shield protector. Observational retrospective single centre study where patients underwent 3 treatment sessions of IPL with 2 weeks of interval. The IPL was carried out with Lumenis OPT M22 with a double pass technique of 12 impacts on the infraorbital/lower eyelid region with the 15 × 35 mm guide light (step 1) and a double pass technique of 3 impacts over the upper eyelids with the 8 × 15 mm guide light (step 2). The follow up was conducted through Oculus Keratograph 5 M. 30 patients were enrolled in the study. Although there were no significant differences (p > 0.05), non-invasive tear break-up time, ocular redness, and OSDI questionnaire improved during the 3 IPL sessions. A significant improvement (p = 0.024) in the percentage of meibomian gland loss was also observed. Regarding tear meniscus, it was found similar measurements before and after treatment. No serious adverse effects were reported during the procedure or in subsequent follow-up. Preliminary results suggest that IPL therapy applied directly on the eyelids without corneal shield could be safe and effective in the treatment of MGD. Nature Publishing Group UK 2022-09-16 /pmc/articles/PMC9481572/ /pubmed/36114213 http://dx.doi.org/10.1038/s41598-022-17986-3 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Martínez-Hergueta, María C.
Alió del Barrio, Jorge L.
Canto-Cerdan, Mario
Amesty, María A.
Efficacy and safety of intense pulsed light direct eyelid application
title Efficacy and safety of intense pulsed light direct eyelid application
title_full Efficacy and safety of intense pulsed light direct eyelid application
title_fullStr Efficacy and safety of intense pulsed light direct eyelid application
title_full_unstemmed Efficacy and safety of intense pulsed light direct eyelid application
title_short Efficacy and safety of intense pulsed light direct eyelid application
title_sort efficacy and safety of intense pulsed light direct eyelid application
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9481572/
https://www.ncbi.nlm.nih.gov/pubmed/36114213
http://dx.doi.org/10.1038/s41598-022-17986-3
work_keys_str_mv AT martinezherguetamariac efficacyandsafetyofintensepulsedlightdirecteyelidapplication
AT aliodelbarriojorgel efficacyandsafetyofintensepulsedlightdirecteyelidapplication
AT cantocerdanmario efficacyandsafetyofintensepulsedlightdirecteyelidapplication
AT amestymariaa efficacyandsafetyofintensepulsedlightdirecteyelidapplication